Where does Renaud Warin work?

Renaud Warin is Chief Scientific Officer at BioCytics.

Where did Renaud Warin go to school?

Renaud Warin studied at Albert Einstein College of Medicine (PhD, Molecular Biology and Genetics); Université de Technologie de Compiègne (UTC) (MSc, Enzymatic Engineering); Université de Picardie Jules Verne (Amiens) (BSc, Molecular Biology and Physiology).

Renaud Warin

Chief Scientific Officer at BioCytics

Concord, North Carolina, United States

Find your path to Renaud

159 people in our graph share verified history with Renaud — schools, employers, funds. One of them is your warm intro.

Matt GurinunlockedRenaud: together at University of Pittsburgh (2008–2009)

Renaud: together at Washington University in St. Louis

Renaud: together at NIH/NIDDK

Renaud: together at Université de Picardie Jules Verne (Amiens)

About

Renaud Warin serves as Chief Scientific Officer at BioCytics Inc. His work covers lab and project management, immunology, cancer prevention, molecular biology, and animal models, with a focus on the isolation, characterization, and modification of immune cell fractions including NK cells, Treg cells, cytotoxic T cells, and gdT cells. He has experience in FDA and cGMP regulated environments and with cell and gene therapy products, including IND development.

Chief Scientific Officer at BioCytics

Co-founders at BioCytics

John PowderlyPresident & CEO

Experience

BioCytics IncChief Scientific Officer, BioCYticscurrent2024 — presentHuntersville, North Carolina, United States
Carolina BioOncology InstituteChief Scientific Officer2023 — 2025Huntersville, North Carolina, United States
Carolina BioOncology InstituteResearch Director2021 — 2023Huntersville, North Carolina, United States
Carolina BioOncology InstituteSenior Scientist - Tumor Immunology2019 — 2021Huntersville, NC
IndependantLife Science and Molecular Biology Consultant2019Charlotte Metro
Dole Food CompanySenior Research Scientist2016 — 2018Kannapolis, NC
North Carolina A&T State UniversityAdjunct Assistant Professor2015 — 2016Kannapolis, NC
North Carolina A&T State UniversityResearch Associate2011 — 2014Kannapolis, NC
Washington University in St. LouisStaff Scientist2010 — 2011
University of PittsburghResearch Associate2007 — 2009
NIH/NIDDKResearch Fellow2004 — 2007

Skills & more

Molecular Biology5Cancer4Drug Discovery3Immunohistochemistry3Biochemistry4Cell3Immunology3Cell Culture2PCR2Genetics1DNA1ELISA1

+8 more

Western BlottingAnimal ModelsFluorescence MicroscopyProtein ExpressionHigh-Performance Liquid Chromatography (HPLC)BiotechnologyDrug DevelopmentOncology

Languages English · French

Good Manufacturing Practices (GMP) — CITI Program
Good Laboratory Practice (GLP) — CITI Program
GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus) — CITI Program
Good Manufacturing Practices (GMP) — CITI Program
Preventing Workplace Harassment — Emtrain

From Renaud's professional profile.

Frequently asked questions

Who is Renaud Warin?: Renaud Warin serves as Chief Scientific Officer at BioCytics Inc. His work covers lab and project management, immunology, cancer prevention, molecular biology, and animal models, with a focus on the isolation, characterization, and modification of immune cell fractions including NK cells, Treg cells, cytotoxic T cells, and gdT cells. He has experience in FDA and cGMP regulated environments and with cell and gene therapy products, including IND development.
Where does Renaud Warin work?: Renaud Warin is Chief Scientific Officer at BioCytics.
Where did Renaud Warin go to school?: Renaud Warin studied at Albert Einstein College of Medicine (PhD, Molecular Biology and Genetics); Université de Technologie de Compiègne (UTC) (MSc, Enzymatic Engineering); Université de Picardie Jules Verne (Amiens) (BSc, Molecular Biology and Physiology).

Same school

Also attended Albert Einstein College of Medicine21

Perry NisenExecutive Advisor, Private Equity at Sofinnova Ventures Richard StumacherClinical Advisor at Seae Ventures Scott BraunsteinVice-Chairman of the Board and Director at atai Life Sciences Sam GoldbergerManaging Partner at Ambit Health Ventures Gur RoshwalbPartner at aMoon Dr. Yair SapersteinFounder / CEO at Avo

+ 15 more

Also attended Université de Technologie de Compiègne (UTC)24

Guillaume BaxterPartner at Sofinnova Partners Baudouin HuePartner at Karista Olivier MartretPartner at Serena Amir BanifatemiManaging Partner at K5 Ventures Cécile DupontPartner, MD Start Strategy at Sofinnova Partners Lincoln AlmeidaAdvisor at FEA Angels

+ 18 more

Also attended Université de Picardie Jules Verne (Amiens)9

Alain HuriezVenture Partner at Advent Life Sciences Pauline BowmanCompliance Officer at Lauxera Capital Partners Paul BramleyDirector & Consultant at Claret Capital Partners Clément WardzalaDirecteur de publication at Cryptoast Akcan IstifHead of Innovation & Labs at Scientifica Venture Capital Maxime DurandInvestor at Agape Patrimoine

+ 3 more

Shared employers

Also worked at Carolina BioOncology Institute1

John PowderlyPresident & CEO at BioCytics

Also worked at Independant17

Gad HuldaiGeneral Partner | First at Pitango Soraya BornazTechnology Specialist at Underground Ventures Jessica SchwartzFund Controller at Manhattan West Patrick NicoletOperating Partner at Benhamou Global Ventures AshrafFractional Director, Computation at Deep Science Ventures Laure DacharyPartner at Verto

+ 11 more

Also worked at North Carolina A&T State University4

Sung-Jin ChoFounder at Soelect Emmanuel DorleyCo-founder & Head of AI at Constrat Doug SpeightCEO at Triad Growth Partners Salman AzharGeneral Partner at Azimuth Kueski

Also worked at Washington University in St. Louis86

David GoadSenior Associate, Strategic Investment at Echo Health Ventures Wesley M. JonesCo-Founder & Partner at Sage Capital Bill CramsiePartner at Embedded Ventures Jim McKelveyPartner at FINTOP Capital Elise HoffmanGeneral Partner at Cultivation Capital John MernFellow, AI at Prime Movers Lab

+ 80 more